Healthcare -
Biotechnology - NASDAQ - US
$ 9.96
-2.83 %
$ 459 M
Market Cap
-3.36
P/E
URGN - FREE CASH FLOW
Free Cash Flow URGN - UroGen Pharma Ltd.
-97.1 M
LAST VALUE
-5.13%
2 YEAR CAGR
-6.35%
5 YEAR CAGR
-37.09%
10 YEAR CAGR